Nektar Therapeutics | NKTR - Deudores Comerciales

Precio De Mercado
77.50
Cambio Diario
-0.35 -0.45%
Mensual
5.69%
Anual
736.44%
Q2 Expectativa
75.38




Deudores Comerciales Cambio Fecha
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
ALKERMES USD 334.02M 21.08M 2025-12
Alterity Therapeutics Limited AUD 4.57M 1.42M 2025-12
Amgen USD 9.57B 1.08B 2025-12
Baxter International USD 2.01B 231M 2025-12
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
Biogen USD 1.85B 234M 2025-09
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Cara Therapeutics USD 2.24M 2.26M 2025-03
Cipla INR 74.61B 19.39B 2025-09
Dr.Reddys Laboratories INR 104.17B 3.61B 2025-12
Eisai JPY 249.06B 25B 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Exelixis USD 286.92M 24.38M 2025-12
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Grifols EUR 1B 285.88M 2025-12
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
MacroGenics USD 13.37M 55.86M 2025-12
Merck USD 12.12B 596M 2025-09
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Roche Holding CHF 11.9B 460M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Takeda JPY 757.92B 55.68B 2025-12
Teva Pharmaceutical Industries USD 3.71B 101M 2025-12
Xencor USD 29.3M 7.49M 2025-12